Mice bearing PTEN/RB1-deficient prostate adenocarcinoma, after undergoing castration or abiraterone treatment of PTEN/P53-deficient prostate adenocarcinoma, show generation of NEPC14. This evidence concerns the gene PTEN and prostate adenocarcinoma.